Table 2 RT–PCR marker analysis according to lymph node staging (n=78) or patient staging (n=22)
SLN histological staging | Patient staging | |||||
---|---|---|---|---|---|---|
Negative node ( n =57) | ITC ( n =12) | MI ( n =5) | MA ( n =4) | SLN− ( n =16) | SLN+ ( n =6) | |
CK17 | ||||||
Negative | 9 (15.8%) | 2 (16.6%) | 0 (0%) | 0 (0%) | 13 (81%) | 0 (0%) |
Positive | 48 (84.2%) | 10 (83.3%) | 5 (100%) | 4 (100%) | 3 (19%) | 6 (100%) |
SSCA | ||||||
Negative | 36 (63.1%) | 6 (50%) | 0 (0%) | 0 (0%) | 15 (94%) | 0 (0%) |
Positive | 21 (36.8%) | 6 (50%) | 5 (100%) | 4 (100%) | 1 (6%) | 6 (100%) |
PVA | ||||||
Negative | 57/57 (100%) | 12/12 (100%) | 0 (0%) | 0 (0%) | 16 (100%) | 0 (0%) |
Positive | 0 (0%) | 0 (0%) | 5 (100%) | 4 (100%) | 0 (0%) | 6 (100%) |